Peptides by condition · Hormones and sexual health

Peptides studied for growth hormone deficiency

Checked against our study pages and the FDA labelsPublished by PepVault

Our library holds 7 study pages on growth hormone deficiency: 6 in people (5 of them meta-analyses or randomized trials), and 1 in animals. They studied 3 compounds, with this many study pages each: HGH 5, MK-677 1 and CJC-1295 with DAC 1.

What the research on growth hormone deficiency looks like

Growth hormone deficiency means the pituitary gland, at the base of the brain, makes too little growth hormone. In children it slows growth in height; in adults it can bring more body fat, less muscle and weaker bones. The studies here are mostly in children and test lab-made growth hormone, given as a daily shot or in newer weekly forms, and one pill that makes the body release more of its own.

Trials in children measure height velocity, how many centimeters a child grows in a year, against the child’s own rate before the shots began or against daily growth hormone. Studies in adults measure IGF-1, a blood hormone that rises with growth hormone.

Most of these trials compared a weekly form with daily growth hormone rather than with placebo, so they show whether it keeps up, not whether growth hormone acts at all. Look at whether the children were before puberty, since growth speeds up in puberty on its own.

Our study pages on growth hormone deficiency by design: Trials in people 5, Other in people 1, Animals 1, Cells 0, of 7.Trials in people5Other in people1Animals1Cells0
How many of the 7 study pages on this condition reach each design, strongest at the top: meta-analyses and randomized trials in people, other studies in people, animals, cells.
A smiling man in an olive shirt leaning on a porch railing with his phone

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The 7 studies, by compound

Grouped by the compound each study is filed under, and within each, strongest design first. Each line gives the design, who was studied, how many and the year, before the finding.

  1. HGH

    5 in people

    For growth hormone deficiency, 5 of our study pages are filed under HGH: 1 meta-analysis, 3 randomized trials and 1 clinical trial in people. The largest in people pooled 1,393 people and was published in 2025. They were published from 1987 to 2025, in Sci Rep, J Clin Endocrinol Metab, Horm Res Paediatr and Acta Paediatr Scand Suppl.

    FDA-approved, with a use tied to growth hormone deficiency on its label: Humatrope (injection) for growth failure in children who make too little growth hormone and several other causes of short stature, and growth hormone deficiency in adults.

  2. MK-677

    1 in people

    For growth hormone deficiency, 1 of our study pages is filed under MK-677: 1 randomized trial in people. It enrolled 9 people and was published in 1997, in J Clin Endocrinol Metab.

    MK-677 (ibutamoren) has no FDA-approved product: Drugs@FDA lists no application for it.

  3. CJC-1295 with DAC

    1 in animals

    For growth hormone deficiency, 1 of our study pages is filed under CJC-1295 with DAC: 1 animal study (mice). It was published in 2006, in Am J Physiol Endocrinol Metab.

    CJC-1295 has no FDA-approved product: Drugs@FDA lists no application for it.

Side by side

For the 3 compounds on this page: studies in people, studies in animals or cells, the size of the largest study in people, and the FDA status from the labels our status pages read (a dash where they hold no record).

CompoundIn peopleAnimals or cellsLargest in peopleFDA
HGH501,393Approved, a use tied to it
MK-677109Not approved
CJC-1295 with DAC01—Not approved

What the studies did not show

Each study page names its own limits. These are the questions still open, in the study pages’ words.

This page is a reading of published studies, not medical advice. A diagnosis, and what to do about it, is a conversation with a clinician.

Questions

Which peptides have been studied for growth hormone deficiency?

Our 7 study pages on growth hormone deficiency are filed under 3 compounds, with this many each: HGH 5, MK-677 1 and CJC-1295 with DAC 1. HGH has the most.

Have any been tested in people with growth hormone deficiency?

Yes: 6 of the 7 were in people, 5 of them meta-analyses or randomized trials (HGH and MK-677). The largest pooled 1,393 people: “HGH: long-acting PEG form beat daily HGH on height at 12 months” (2025).

Is any peptide FDA-approved for growth hormone deficiency?

Yes, with a use tied to growth hormone deficiency on their FDA labels: HGH as Humatrope. 2 other compounds here with an FDA record have no use tied to it.

How large were the studies in people on growth hormone deficiency?

Of the 6 in people, all give their size on our pages: 1 had 1,000 people or more, 2 had 100 to 999 and 3 had fewer than 100. The largest, a meta-analysis from 2025, pooled 1,393.

What did the animal and cell studies on growth hormone deficiency use?

1 animal study (mice), filed under CJC-1295 with DAC. A result in animals or cells shows what to test next, not what happens in a person.

What is the newest study on growth hormone deficiency here?

Of our study pages on growth hormone deficiency, the newest is “HGH: long-acting PEG form beat daily HGH on height at 12 months”, a meta-analysis in people published in 2025.

How this page was built

A study page is listed here only where we read its question, design and finding and the study was about this condition: its subjects had the condition, or were an animal or cell model of it, and the study gave them the compound. A study that only mentions the condition is not listed.

Studies are grouped by the compound each is filed under and ordered by design: meta-analyses and randomized trials in people first, then other studies in people, then animals, then cells, and within a group by size and then by year. The FDA status comes from the labels our legal-status and brand pages read.

Track it in the app

PepVault for iPhone

Track your own progress in PepVault

Doses, vials, weight and side effects in one log.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo